BioXcel Therapeutics (BTAI) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist

0.364
+0.006+1.54%

Close Jan 22 16:00 ET

0.350
-0.014-3.71%

Post 19:21 ET

18.04MMarket Cap-0.18P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Bioxcel Therapeutics Appoints Dr. Rajiv Patni to Board
TipRanksJan 16 08:28 ET
Express News | BioXcel Therapeutics Inc - Increases Board Size to Eight Directors
ReutersJan 16 08:01 ET
Express News | BioXcel Therapeutics Inc Files for Resale of up to 5.1 Mln Shares by the Selling Stockholders - SEC Filing
ReutersJan 10 16:46 ET
Bioxcel Therapeutics Revises Executive Compensation Structure
TipRanksJan 8 08:18 ET
BioXcel Therapeutics Cut to Underperform From Buy by B of A Securities
Dow JonesJan 7 12:54 ET · Ratings
BofA Securities Downgrades BioXcel Therapeutics(BTAI.US) to Sell Rating, Announces Target Price $0.25
Moomoo NewsJan 7 07:36 ET · Ratings

Comments

71735916

Jan 6 10:58

Gap up?

$BioXcel Therapeutics (BTAI.US)$ 👀👀

disrudog

Jan 6 10:50

$BioXcel Therapeutics (BTAI.US)$
future of stock, medical is a new trend

Jaguar8

Dec 15, 2024 20:58

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...